| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.8M | +12.9% |
| Cost of Revenue | $23.1M | -26.0% |
| Gross Profit | -$10.3M | +48.1% |
| R&D Expense | $110K | +226.8% |
| SG&A Expense | $5.7M | +22.7% |
| Operating Income | -$19.8M | +24.7% |
| Pre-tax Income | -$19.8M | +25.0% |
| Income Tax | $164K | +125.2% |
| Net Income | -$20.0M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.3M | -28.2% |
| Accounts Receivable | $103K | -79.9% |
| Inventory | $17.7M | -46.2% |
| Current Assets | $25.6M | -40.9% |
| Total Assets | $29.5M | -36.5% |
| Current Liabilities | $1.8M | -10.4% |
| Total Liabilities | $6.1M | +9.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | -130.4% |
| Capital Expenditures | $155K | -57.6% |
| Investing Cash Flow | -$155K | -123.0% |
| Financing Cash Flow | $2.8M | +492.4% |
| Free Cash Flow | -$4.9M | -102.3% |
| +23.5% |
| Stockholders' Equity |
| $23.4M |
| -42.7% |